Overview
Aki Manninen practices practicing medicine in Oulu, Finland.
Their clinical expertise encompasses Cerebral Hypoxia, Bowen's Disease, Prostate Cancer, and Breast Cancer.
They are actively involved in clinical research, co-authoring 44 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Aki J. Manninen
Is Aki J. Manninen a top-rated expert for Cerebral Hypoxia?
MediFind is an objective health platform that identifies experts based on real-world data. Aki J. Manninen is classified as an Experienced expert for Cerebral Hypoxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Aki J. Manninen participate in research or clinical trials?
Yes. Aki J. Manninen has published 44 articles and abstracts on conditions like Cerebral Hypoxia. You can view a list of Aki J. Manninen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bowen's DiseaseManninen isExperienced. Learn about Bowen's Disease.
- Breast CancerManninen isExperienced. Learn about Breast Cancer.
- Cerebral HypoxiaManninen isExperienced. Learn about Cerebral Hypoxia.
- Prostate CancerManninen isExperienced. Learn about Prostate Cancer.